TNM002 Injection

TNM002 · Zhuhai Trinomab Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TNM002 Injection, covering 2024-03-08 to 2024-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus [Phase 3]

See pricing